Scientific gaps in the prediction and prevention of sudden cardiac death

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 7, 2002, Pages 709-723

  Myerburg, Robert J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Epidemiology; Genetics

Indexed keywords

CORONARY ARTERY ATHEROSCLEROSIS; GENETIC MARKER; HEART ARRHYTHMIA; HUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SUDDEN DEATH; CHANNEL GATING; ELECTROPHYSIOLOGY; GENETICS; PHYSIOLOGY; POPULATION DYNAMICS;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; POPULATION DYNAMICS;

EID: 0035996747     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2002.00709.x     Document Type: Review

References (126)

1. Sudden cardiac death. Structure, function, and time-dependence of risk
2. Cardiac arrest and sudden cardiac death
3. Sudden cardiac death: Exploring the limits of our knowledge
4. International comparisons in ischemic heart disease mortality
5. Comparison of sudden and nonsudden coronary deaths in the United States
6. Sudden cardiac death in the United States, 1989 to 1998
7. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
8. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
9. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
10. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
11. A randomized study of the prevention of sudden death in patients with coronary artery disease
12. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
13. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II
14. Prophylactic implantation of defibrillators in patients with myocardial infarction and reduced ejection fraction
15. Opportunities for sudden death prevention: Directions for new clinical and basic research
16. New approaches to antiarrhythmic therapy - Emerging therapeutic applications of the cell biology of cardiac arrhythmias. Part I
17. Part II
18. Atherosclerosis: An inflammatory disease?
19. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
20. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
21. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
22. Reaction of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial
23. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
24. Sudden death in coronary artery disease: Acute ischemia versus myocardial substrate
25. Cellular electrophysiology, heterogeneity, and arrhythmias
26. + channel diversity in the mammalian myocardium
27. Differences in transient outward currents of feline endocardial and epicardial myocytes
28. Potassium rectifier currents differ in myocytes of endocardial and epicardial origin
29. Differences in the effect of metabolic inhibition on action potentials and calcium currents in endocardial and epicardial cells
30. Electrophysiological properties and responses to simulated ischemia in cat ventricular myocytes of endocardial and epicardial origin
31. Role of cardiac ATP-regulated potassium channels in differential responses of endocardial and epicardial cells to ischemia
32. ks contributes to the longer action potential of the M cell
33. A model of cardiac electrical activity incorporating ionic pumps and concentration changes
34. A dynamic model of the cardiac ventricular action potential, I. Simulations of ionic currents and concentration changes
35. II. Afterdepolarizations, triggered activity, and potentiation
36. Molecular mechanisms of myocardial remodeling
37. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
38. Adenovirus E1A inhibits cardiac myocyte-specific gene expression through its amino terminus
39. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling
40. + channels
41. Electrophysiological consequences of chronic, experimentally induced left ventricular pressure overload
42. Diminished transient outward currents in rat hypertrophied ventricular myocytes
43. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction
44. 4. 3 mRNA correlates with a reduction in current density
45. K differs in feline left ventricular hypertrophy
46. Functional significance of hypertrophy of the noninfarcted myocardium after myocardial infarction in humans
47. Morphometric mapping of regional myocyte diameters after healing of myocardial infarction in cats
48. Regional increase in isolated myocyte volume in chronic myocardial infarction in cats
49. K and its response to quinidine in experimental healed myocardial infarction
50. Regional gradation of L-type calcium currents in the feline heart with a healed myocardial infarct
51. The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy
52. 2+ window current in heart cells
53. The cytoskeleton and cell signaling: Component localization and mechanical coupling
54. Calcium ions and tyrosine phosphorylation interact coordinately with actin to regulate cytoprotective responses to stretching
55. Cytoskeletal actin microfilaments and the transient outward potassium current in hypertrophied rat ventriculocytes
56. B knockout mice
57. Mapping of a new gene for the LQTS syndrome
58. Anchors aweigh!: Ion channels, cytoskeletal proteins, and cellular excitability
59. Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey ras-1 gene
60. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
61. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
62. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
63. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome
64. Ks function
65. IsK and KvLQT1: Mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome
66. Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death
67. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
68. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
69. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management, Parts I and II
70. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis
71. MinK-related peptide 1 associates with Kv4. 2 and modulates its gating function: Potential role as β subunit of cardiac transient outward channel?
72. Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: Evidence for variable hearing phenotype associated with R518X
73. Concealed arrhythmogenic syndromes: The hidden substrate of idiopathic ventricular fibrillation?
74. Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1
75. A common polymorphism associated with antibiotic-induced cardiac arrhythmia
76. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
77. Multiple mechanisms in the long-QT syndrome: Current knowledge, gaps, and future directions
78. Proarrhythmia
79. Drug-induced torsade de pointes: Incidence, management and prevention
80. Low penetrance in the long-QT syndrome: Clinical impact
81. Family history as a risk factor for primary cardiac arrest
82. Predicting sudden death in the population: The Paris Prospective Study I
83. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute Workshop, Part I
84. A molecular link between the sudden infant death syndrome and the long-QT syndrome
85. DNA synthesis in adult feline ventricular myocytes: Comparison of hypoxic and normoxic states
86. Evidence that human cardiac myocytes divide after myocardial infarction
87. Genetic susceptibility to death from coronary heart disease in a study of twins
88. Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension
89. Genetic analysis of atherosclerosis: A research paradigm for the common chronic diseases
90. Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
91. Recent advances in molecular genetics of cardiovascular disorders: Implications for atherosclerosis and diseases of cellular lipid metabolism
92. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans
93. Identification of genes potentially involved in rupture of human atherosclerotic plaques
94. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions
95. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
96. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
97. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
98. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease
99. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction
100. Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis
101. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients
102. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
103. Apolipoprotein E deficiency in mice: Gene replacement and prevention of atherosclerosis using adenovirus vectors
104. -786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm
105. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity
106. Heritability of heart rate variability. The Framingham Heart Study
107. Prognostic factors: Guidelines for investigation design and state of the art analytical methods
108. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials
109. Final report on the aspirin component of the ongoing Physicians' Health Study
110. An assessment of clinically useful measures of the consequences of treatment
111. Interpretation of outcomes of antiarrhythmic clinical trials. Design features and population impact
112. Sudden death due to cardiac arrhythmias
113. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia
114. 2+ current: A cellular mechanism for long Q-T arrhythmias
115. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel
116. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure
117. Chromosomal organization of adrenergic receptor genes
118. 2-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias
119. 1-adrenoceptor gene variations: A role in idiopathic dilated cardiomyopathy?
120. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death
121. Modulation of the delayed rectifier potassium current in frog cardiomyocytes by beta-adrenergic agonists and magnesium
122. 2-adrenergic stimulation in animals susceptible to sudden death
123. 3-adrenoreceptors to the KvLQT1/Mink potassium channel
124. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness
125. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL